| Clinical data | |
|---|---|
| Other names | UR-AK49 |
| Identifiers | |
| |
| CAS Number | |
| PubChemCID | |
| ChemSpider |
|
| UNII | |
| ChEMBL | |
| CompTox Dashboard(EPA) | |
| Chemical and physical data | |
| Formula | C16H27N5O |
| Molar mass | 305.426 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| (verify) | |
UR-AK49 is a drug used in scientific research which acts as a potentantagonist for theNeuropeptide Y /Pancreatic polypeptidereceptorY4, and also as apartial agonist at thehistamine receptorsH1 andH2.[1] UR-AK49 is a pure antagonist at Y4 with no partial agonist effects, and although it is only slightly selective for Y4 over the relatedY1 andY5 receptors, as the first non-peptide Y4 antagonist developed UR-AK49 is expected to be useful in the study of this receptor and its role in the body.[2]
Thisdrug article relating to thenervous system is astub. You can help Wikipedia byexpanding it. |